Utility of 18F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy

被引:0
作者
In Hee Lee
Soo Jung Lee
Jeeyeon Lee
Jin Hyang Jung
Ho Yong Park
Shin Young Jeong
Sang-woo Lee
Yee Soo Chae
机构
[1] Catholic University of Daegu,Department of Oncology/Hematology
[2] School of medicine,Department of Oncology/Hematology
[3] Kyungpook National University Chilgok Hospital,Department of Breast and Thyroid Surgery
[4] Kyungpook National University,Department of Nuclear Medicine
[5] Kyungpook National University Chilgok Hospital,undefined
[6] Kyungpook National University,undefined
[7] Kyungpook National University Chilgok Hospital,undefined
[8] Kyungpook National University,undefined
来源
BMC Cancer | / 20卷
关键词
Breast cancer; Neoadjuvant chemotherapy; Pathologic complete response; SUVmax;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 283 条
[1]  
Fisher B(1997)Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and bowel project B-18 J Clin Oncol 15 2483-2493
[2]  
Brown A(2001)Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902 J Clin Oncol 19 4224-4237
[3]  
Mamounas E(1999)Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonie Bordeaux Groupe Sein (IBBGS) Ann Oncol 10 47-52
[4]  
Wieand S(2008)Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease J Clin Oncol 26 814-819
[5]  
Robidoux A(2008)Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and bowel project protocols B-18 and B-27 J Clin Oncol 26 778-785
[6]  
Margolese RG(2005)Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis J Natl Cancer Inst 97 188-194
[7]  
Cruz AB(2010)Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features Breast Cancer Res Treat 124 689-699
[8]  
Fisher ER(2011)Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients Eur J Cancer 47 2084-2090
[9]  
Wickerham DL(1999)Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy J Clin Oncol 17 460-469
[10]  
Wolmark N(2012)Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes J Clin Oncol 30 1796-1804